Skip to main content

Dr. Amanj Kurdi

Biography

Amanj holds the position of Reader (Associate Professor) in Pharmacoepidemiology and Pharmacy Practice at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom. His research endeavours are deeply rooted in the field of Pharmacoepidemiology and Drug Utilisation Research, with a primary objective of enhancing the rational use of medications on both a national and international scale, particularly in Low- to Middle-Income Countries. His focus areas include antimicrobial resistance and stewardship, as well as the management of non-communicable diseases, notably cardiovascular diseases and diabetes. These efforts are undertaken in collaboration with interdisciplinary teams. Furthermore, Amanj has cultivated expertise in the investigation of medication adherence and persistence, alongside Health Services Research. This includes the development, implementation, and evaluation of healthcare interventions. His methodological approach is characterised using mixed methods, implementation science, and the analysis of linked electronic health records through various advanced statistical techniques, including multilevel modelling and time series analysis. Amanj's publication portfolio is distinguished by an extensive array of over 130 peer-reviewed articles, featured in prestigious and influential journals, including but not limited to, The Lancet and Nature Medicine.

Research Interests

Internal Medicine| Vaccinology | Epidemiology | Tropical and Infectious diseases| Zoonotic infections| Neglected Tropical Diseases

Recent Publications

2024

Mahmoud F, Mueller T, Mullen A, Sainsbury C, Rushworth GF, Kurdi A. Patterns of initial and first-intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010-2020: A retrospective population-based cohort study. Diabetes Obes Metab. 2024 Jul;26(7):2684-2694. doi: 10.1111/dom.15584. Epub 2024 Apr 1. PMID: 38558305.

2023

(2023). Trends in the Cost of Medicines, Consultation Fees and Clinic Visits in Malaysia’s Private Primary Healthcare System: Employer Health Insurance Coverage. Journal of Multidisciplinary Healthcare, 16, 1683–1697. https://doi.org/10.2147/JMDH.S403589

Zin, C. S., Ab Rahman, N. S.Zin, C. S., Ab Rahman, N. S., Mohamed Nazar, N. I., Kurdi, A., & Godman, B. (2023). Trends in the Cost of Medicines, Consultation Fees and Clinic Visits in Malaysia’s Private Primary Healthcare System: Employer Health Insurance Coverage. Journal of Multidisciplinary Healthcare16, 1683–1697. https://doi.org/10.2147/JMDH.S403589

2020

Mahmoud F, Mueller T, Mullen A, Sainsbury C, Rushworth GF, Kurdi A. Patterns of initial and first-intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010-2020: A retrospective population-based cohort study. Diabetes Obes Metab. 2024 Jul;26(7):2684-2694. doi: 10.1111/dom.15584. Epub 2024 Apr 1. PMID: 38558305.